Drugs Made In America Acquisition Corp
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
10.7M
on 2026-06-30, from 9.86M on 2024-12-31 10-Q ↗
a raise that quarter, at its price
Newest
None
No S-3 or F-3 shelf on file in the last 30 months.
None
No at-the-market programme on file in the last 30 months.
Warrants
The 10-Q filed 2026-08-14 is not read yet.
Cash
0.2 quarters
$20K on 2026-06-30 ÷ $129K a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2025-01-29 | Public offering | not read | not read | $200.0M | 424B4 ↗ |